The University of Missouri is set to announce a significant development in its Mizzou’s NextGen Nuclear Research Reactor that will enhance cancer-fighting research and medical isotope production at MU. The reactor will play a crucial role in producing medical isotopes used in cancer treatments and diagnosing diseases like cancer and heart disease. By eliminating tumors without harming surrounding cells, these isotopes are valuable in medical treatments.
In an effort to advance the project, MU has opened a request for qualifications for consultants to assist in the initial design phase of the reactor. The selected consultant will work alongside MU staff to oversee the design process, with an expected cost of $10 million for the first 18-24 months of the project.
The university is inviting the media to join the announcement of this milestone development at 10 a.m. on Wednesday at the Jesse Hall rotunda. This advancement signifies a significant step forward in nuclear research and medical advancements at the University of Missouri. Stay tuned for further updates on this groundbreaking project.
Note: The image is for illustrative purposes only and is not the original image associated with the presented article. Due to copyright reasons, we are unable to use the original images. However, you can still enjoy the accurate and up-to-date content and information provided.
